Phillygenin Exerts In Vitro and In Vivo Antitumor Effects in Drug-Resistant Human Esophageal Cancer Cells by Inducing Mitochondrial-Mediated Apoptosis, ROS Generation, and Inhibition of the Nuclear Factor kappa B NF-κB Signalling Pathway
Type
Retraction
Notice date
3/25/2021 0:00
Journal
Medical Science Monitor: International Medical Journal of Experimental and Clinical Research